GlassScriptPhysician profile
Keith D Bowersox
NPI 1669474870
$7,477.39
in general payments reported to CMS, 2019-2025
15 companies · $18.55 in 2025
The $18.55 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,040 · 2020: $252 · 2021: $212 · 2022: $3,525 · 2023: $86.38 · 2024: $343 · 2025: $18.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,402.04 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $2,961.00 | 2022 | |
| Edwards Lifesciences Corporation | $313.88 | 2019-2024 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $138.32 | 2020 | |
| Pinnacle Biologics, INC | $119.08 | 2019-2023 | Photofrin |
| Zimmer Biomet Holdings, INC. | $114.00 | 2020 | |
| Kerecis Limited | $102.30 | 2019 | |
| Atricure, INC. | $77.23 | 2021-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Conmed Corporation | $71.43 | 2019 | |
| Becton, Dickinson and Company | $60.16 | 2019 | |
| Erbe USA INC | $25.97 | 2023 | |
| Tesaro, INC. | $25.28 | 2019 | |
| Abiomed | $24.52 | 2021 | |
| Genentech USA, INC. | $23.74 | 2024 | Tecentriq |
| Kls-Martin L.P. | $18.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Bowersox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.